The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...

Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

Tidmarsh, MD, PhD, is to oversee the safety and effectiveness of over-the-counter and prescription drugs at the CDER.

U.S. Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the ...

Tidmarsh, an adjunct professor at Stanford’s medical school, brings decades of industry experience to the table. Serving as ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...

George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...